{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:19:29Z","timestamp":1778275169610,"version":"3.51.4"},"reference-count":11,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Case Reports"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Morphea is a localized autoimmune fibrosing disorder that may paradoxically develop during anti\u2010TNF\u03b1 agents in ankylosing spondylitis (AS). We report a second case of morphea associated with long\u2010term golimumab use in a patient with AS, presenting with indurated plaques and confirmed histopathologically. This case highlights the importance of clinical vigilance and timely dermatologic assessment to determine whether morphea represents a drug\u2010induced reaction or an extra\u2010articular manifestation of AS.<\/jats:p>","DOI":"10.1002\/ccr3.72622","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:09:01Z","timestamp":1777007341000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Morphea Induced by Golimumab in a Patient With Ankylosing Spondylitis: A Case Report and Literature Review"],"prefix":"10.1002","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4145-3977","authenticated-orcid":false,"given":"Faten","family":"Hilwanjee","sequence":"first","affiliation":[{"name":"Department of Rheumatology Ibn Al\u2010Nafees Hospital  Damascus Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7169-1296","authenticated-orcid":false,"given":"Yumn","family":"Alghabra","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Ibn Al\u2010Nafees Hospital  Damascus Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad","family":"Aldalati","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Ibn Al\u2010Nafees Hospital  Damascus Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-4581","authenticated-orcid":false,"given":"Nada","family":"Al Chama","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Ibn Al\u2010Nafees Hospital  Damascus Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1108623","article-title":"Morphea: The 2023 Update","volume":"10","author":"Papara C.","year":"2023","journal-title":"Frontiers in Medicine"},{"issue":"2","key":"e_1_2_13_3_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5606\/ArchRheumatol.2014.3919","article-title":"Coexistence of Ankylosing Spondylitis With Morphea: A Case Report","volume":"29","author":"G\u00fcm\u00fc\u015fsu K.","year":"2014","journal-title":"Archives of Rheumatology"},{"key":"e_1_2_13_4_1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/s10165-011-0550-4","article-title":"Morphea Associated With the Use of Adalimumab: A Case Report and Review of the Literature","volume":"22","author":"Ram\u00edrez J.","year":"2012","journal-title":"Modern Rheumatology"},{"issue":"4","key":"e_1_2_13_5_1","first-page":"303","article-title":"Linear Localized Morphea Associated With Golimumab in a Patient With Spondyloarthritis","volume":"16","author":"Torrente\u2010Segarra V.","year":"2018","journal-title":"Reumatologia Clinica"},{"issue":"1","key":"e_1_2_13_6_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.reumae.2012.07.008","article-title":"Skin Lesions and Treatment With Tumor Necrosis Factor Alpha Antagonists","volume":"9","author":"Hern\u00e1ndez M. V.","year":"2013","journal-title":"Reumatolog\u00eda Cl\u00ednica"},{"key":"e_1_2_13_7_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1724","article-title":"Dermatological Conditions During TNF\u2010\u03b1\u2010Blocking Therapy in Patients With Rheumatoid Arthritis: A Prospective Study","volume":"7","author":"Flendrie M.","year":"2005","journal-title":"Arthritis Research & Therapy"},{"issue":"3","key":"e_1_2_13_8_1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous Side\u2010Effects in Patients With Rheumatic Diseases During Application of Tumour Necrosis Factor\u2010\u03b1 Antagonists","volume":"156","author":"Lee H.","year":"2007","journal-title":"British Journal of Dermatology"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.1027"},{"issue":"3","key":"e_1_2_13_10_1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pde.15182","article-title":"Tumor Necrosis Factor\u2010\u03b1 Inhibitor\u2010Induced Morphea and Psoriasiform Dermatitis in a Pediatric Patient With Crohn's Disease","volume":"40","author":"Reinhart J. P.","year":"2023","journal-title":"Pediatric Dermatology"},{"issue":"6","key":"e_1_2_13_11_1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.5114\/aoms.2012.32421","article-title":"Interleukin\u201017A and Interleukin\u201023 in Morphea","volume":"8","author":"Da\u0144czak\u2010Pazdrowska A.","year":"2012","journal-title":"Archives of Medical Science"},{"issue":"5","key":"e_1_2_13_12_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri3831","article-title":"Type 2 Cytokines: Mechanisms and Therapeutic Strategies","volume":"15","author":"Wynn T. A.","year":"2015","journal-title":"Nature Reviews. Immunology"}],"container-title":["Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.72622","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ccr3.72622","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.72622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:09:03Z","timestamp":1777007343000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccr3.72622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1002\/ccr3.72622"],"URL":"https:\/\/doi.org\/10.1002\/ccr3.72622","archive":["Portico"],"relation":{},"ISSN":["2050-0904","2050-0904"],"issn-type":[{"value":"2050-0904","type":"print"},{"value":"2050-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"2025-10-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e72622"}}